Literature DB >> 7906214

Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes.

P Aukrust1, F Müller, S S Frøland.   

Abstract

Serum immunoreactive interleukin (IL-)1 alpha, IL-4, IL-6 and tumor necrosis factor (TNF) alpha were measured in 42 patients with primary hypogammaglobulinemia (25 common variable immunodeficiency (CVI), 10 congenital hypogammaglobulinemia (CH), 7 X-linked agammaglobulinemia (XLA), and in 21 healthy controls. The cytokine levels were correlated to other immunological parameters including serum levels of neopterin and soluble CD8 (sCD8) antigen. IL-6 was detectable in 48% and IL-4 in 36% of the CVI patients, but in none of the controls. Seventy-five percent of the CVI patients with elevated IL-4 levels had detectable IL-6. In contrast, no patients in the XLA group and only three CH patients had detectable IL-4 or IL-6 levels. TNF alpha and IL-1 alpha were detected in only a few serum samples with no significant differences between patients and controls. In the CVI group elevated IL-6 levels were significantly associated to reduced numbers of CD4+ and CD19+ lymphocytes, elevated levels of neopterin and sCD8 antigen, and occurrence of splenomegaly and bronchiectasis. The raised IL-6 levels were confirmed in longitudinal testing, probably reflecting a characteristic immunological dysregulation in these patients. Cytokine alterations may play a role in the pathogenesis of the immunodeficiency and for the clinical manifestations in CVI patients. Alternatively, elevated cytokine levels may be only a marker of chronic immune activation, particularly in monocytes, possibly delineating a distinct subgroup of patients within the heterogeneous CVI group.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7906214     DOI: 10.1006/clin.1994.1032

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  22 in total

1.  Enhanced T cell apoptosis in common variable immunodeficiency: negative role of the fas/fasligand system and of the Bcl-2 family proteins and possible role of TNF-RS.

Authors:  M Di Renzo; D Serrano; Z Zhou; I George; K Becker; C Cunningham-Rundles
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

2.  Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency.

Authors:  Timothy J Franxman; Laura E Howe; James R Baker
Journal:  J Clin Immunol       Date:  2014-07-27       Impact factor: 8.317

3.  Administration of intravenous immunoglobulin (IVIG) in vivo--down-regulatory effects on the IL-1 system.

Authors:  P Aukrust; F Müller; M Svenson; I Nordøy; K Bendtzen; S S Frøland
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 4.  Common variable immune deficiency: Dissection of the variable.

Authors:  Charlotte Cunningham-Rundles
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

5.  B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease.

Authors:  Gaël Mouillot; Maryvonnick Carmagnat; Laurence Gérard; Jean-Luc Garnier; Claire Fieschi; Nicolas Vince; Lionel Karlin; Jean-François Viallard; Roland Jaussaud; Julien Boileau; Jean Donadieu; Martine Gardembas; Nicolas Schleinitz; Felipe Suarez; Eric Hachulla; Karen Delavigne; Martine Morisset; Serge Jacquot; Nicolas Just; Lionel Galicier; Dominique Charron; Patrice Debré; Eric Oksenhendler; Claire Rabian
Journal:  J Clin Immunol       Date:  2010-05-01       Impact factor: 8.317

6.  Human cytomegalovirus infection is not increased in common variable immunodeficiency.

Authors:  C G Mullighan; S J Read; A G Bird; J B Kurtz; H M Chapel; K I Welsh
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

7.  Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation.

Authors:  S F Jørgensen; M Trøseid; M Kummen; J A Anmarkrud; A E Michelsen; L T Osnes; K Holm; M L Høivik; A Rashidi; C P Dahl; M Vesterhus; B Halvorsen; T E Mollnes; R K Berge; B Moum; K E A Lundin; B Fevang; T Ueland; T H Karlsen; P Aukrust; J R Hov
Journal:  Mucosal Immunol       Date:  2016-03-16       Impact factor: 7.313

8.  Adhesion molecules in common variable immunodeficiency (CVID)--a decrease in L-selectin-positive T lymphocytes.

Authors:  I Nordøy; F Müller; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

9.  Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency.

Authors:  P Aukrust; F Müller; S S Frøland
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

10.  Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications.

Authors:  Nima Rezaei; Mostafa Haji-Molla-Hoseini; Asghar Aghamohammadi; Ali Akbar Pourfathollah; Mina Moghtadaie; Zahra Pourpak
Journal:  J Clin Immunol       Date:  2007-10-03       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.